Uniquely positioned with wide ranges of products

Our startup is uniquely positioned by offering wide ranges of product, which is a key differentiator in the competitive Gastroenterology market landscape. Unique products are offered to achieve specific needs or patient compliance, allowing healthcare professional to provide tailored solutions for the larger patient population.

ver the past two decades, gastrointestinal diseases have become a major health concern in India & other Asian populations, with a significant rise in both incidence and prevalence. As a result, GI diseases are now leading causes of morbidity and mortality across Asian countries.

While infectious diseases such as Diarrhea, Hepatitis, Typhoid, and intestinal tuberculosis remain prevalent, there is a growing concern over the rise of Lifestyle-Related disorders. Conditions like Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease (GERD), Inflammatory Bowel Diseases such as Crohn’s disease, non alcoholic fatty liver disease, and cancers of the esophagus, colon, liver, pancreas, and gallbladder are becoming increasingly common.

Recognizing these trends, Oeuvre Healthcare sees significant opportunities in the expanding gastrointestinal therapy market in India and neighboring Asian nations. The company focuses on delivering innovative, high-quality medications to address the evolving challenges and unmet needs of patients suffering from GI diseases.